Skip to main content

Table 5 Drug-administration by regimen, n = 726

From: Treatment completion for latent tuberculosis infection in Norway: a prospective cohort study

Drug administration

3RHa daily

3RPHb weekly

Otherc

Total

Number of individuals

399 (100)

306 (100)

21 (100)

726 (100)

Self-administered

220 (55)

20 (7)

14 (67)

254 (35)

Direct observed treatment

 Whole period

132 (33)

269 (88)

3 (14)

404 (56)

 Part of period

41 (10)

11 (4)

3 (14)

55 (8)

 Missing information

6 (2)

6 (2)

1 (5)

13 (2)

  1. Data are presented as n (%)
  2. arifampicin (R) and isoniazid (H) daily for three months
  3. brifapentine (RP) and isoniazid (H) in 12 weekly doses
  4. cIrifampicin (R) monotherapy daily for four months (n = 5), Isoniazid (H) monotherapy for six months (n = 13) or combination therapy for TB disease (n = 2) and missing information (n = 1)
  5. dOther included: hospital outpatient clinic, assisted living facilities, refugee centres, work-places or with general practitioners.